Market Moves
Humana becomes first Medicare Advantage payer to cover CVRx Barostim heart-failure therapy
Humana issues the first Medicare Advantage coverage policy for CVRx's Barostim baroreflex neuromodulation therapy effective 1 May 2026, the fourth 2026 reimbursement and trial milestone for the bioelectronic heart-failure category.